← Back to Search

Family Support Program for Depression

N/A
Recruiting
Led By Adam Davey, Ph.D.
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 months
Awards & highlights

Study Summary

This trialtests a family program to help African American parents/caregivers and their teens cope with cancer & depression.

Who is the study for?
This trial is for non-Hispanic Black parents or primary caregivers newly diagnosed with early-stage solid tumor or hematologic cancer, who have at least one adolescent child living at home. The parent must have informed their child about the diagnosis.Check my eligibility
What is being tested?
The study tests a family-based program aimed to help African American families communicate better and reduce depression in adolescents when a parent has been diagnosed with cancer.See study design
What are the potential side effects?
Since this trial involves psychoeducation and family therapy, there are no medical side effects. However, participants may experience emotional discomfort discussing sensitive topics.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Reduce 8-week depressive symptoms among African American adolescents on the Child Depression Inventory (CDI-2)
Other outcome measures
Reduce 8-week parental stress among African American parents on the Parenting Concerns Questionnaire (PCQ)
Reduce depressive symptoms among African American adolescents on the Child Depression Inventory (CDI-2)
Reduce depressive symptoms among African American adolescents on the Revised Children's Manifest Anxiety Scale (RCMAS-2)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ExperimentalExperimental Treatment1 Intervention
Family-based attachment-focused intervention for families where parent/caregiver is within 12 months of first diagnosis of a stage I-III solid tumor cancer.
Group II: PsychoeducationActive Control1 Intervention
Provides equivalent number of American Cancer Society psychoeducational sessions.

Find a Location

Who is running the clinical trial?

University of DelawareLead Sponsor
154 Previous Clinical Trials
25,011 Total Patients Enrolled
Helen F. Graham Cancer Center & Research Institute at Christiana CareUNKNOWN
Sidney Kimmel Cancer Center at Thomas Jefferson UniversityOTHER
162 Previous Clinical Trials
10,711 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current recruitment figure for this research endeavor?

"Affirmative. The information on clinicaltrials.gov confirms that this experiment, which was first publicized on October 2nd 2018, is currently enrolling participants. This endeavour will require 200 individuals to be recruited from two distinct sites."

Answered by AI

Is enrollment available for this trial at the current moment?

"Indeed, the data on clinicaltrials.gov indicate that this trial is still actively seeking volunteers. It was initially posted in October of 2018 and its information has been updated as recently as November 8th 2022. The study requires 200 participants to be recruited across two different treatment sites."

Answered by AI
~6 spots leftby Jun 2024